Point72 Asset Management
FPRX

Point72 Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Point72 Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-201,700
Closed -$4.42M – 1198
2017
Q4 		$4.42M Buy
201,700
+138,718
+220% +$4.46M 0.02% 619
2017
Q3 		$2.58M Buy
+62,982
New +$1.98M 0.01% 647
2017
Q2 		– Sell
-19,569
Closed -$707K – 1064
2017
Q1 		$707K Buy
+19,569
New +$863K ﹤0.01% 758
2016
Q3 		– Sell
-19,200
Closed -$794K – 904
2016
Q2 		$794K Buy
+19,200
New +$835K 0.01% 641
2015
Q4 		– Sell
-4,600
Closed -$71K – 897
2015
Q3 		$71K Sell
4,600
-474,811
-99% -$10.2M ﹤0.01% 714
2015
Q2 		$11.9M Sell
479,411
-545,289
-53% -$12.1M 0.08% 289
2015
Q1 		$23.4M Buy
1,024,700
+457,300
+81% +$11.5M 0.16% 179
2014
Q4 		$15.3M Buy
+567,400
New +$9.77M 0.11% 256

Other funds holding FPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Point72 Asset Management's FPRX Position: Q1 2018 in Review

Point72 Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2018, closing a stake of 201,700 shares — an estimated $4.42M sold.

Point72 Asset Management first reported a position in FPRX in Q4 2014 and held it in 8 quarters. The position peaked at $23.4M in Q1 2015. 128 funds tracked by Wall St. Rank hold FPRX as of Q1 2018.

  • Point72 Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Point72 Asset Management sold 201,700 Five Prime Therapeutics, Inc. shares in Q1 2018, an estimated $4.42M.
  • Point72 Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q4 2014 and held it in 8 quarters.
  • Point72 Asset Management's Five Prime Therapeutics, Inc. position peaked at $23.4M in Q1 2015.
  • 128 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2018.

Based on Point72 Asset Management's 13F filing for Q1 2018, filed 15 May 2018.